Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Buy Bristol-Myers Calls as Stock May Advance, Goldman Says
Buy Bristol-Myers Calls as Stock May Advance, Goldman Says
Buy Bristol-Myers Calls as Stock May Advance, Goldman Says
Submitted by
admin
on March 3, 2011 - 5:52pm
Source:
Bloomberg
News Tags:
Bristol-Myers Squibb
melanoma
ipilimumab
Headline:
Buy Bristol-Myers Calls as Stock May Advance, Goldman Says
Do Not Allow Advertisers to Use My Personal information
